FDA approval of Filkri expands Accord’s G-CSF biosimilar portfolio, offering a short-acting option for neutropenia in cancer care.

BLA resubmitted to U.S. FDA in January 2026; Company expects up to six-month review period per FDA guidelines NOVATO, Calif., Feb. 03, 2026 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (RARE) ...

GENT, Belgium & MALVERN, Pa. & TOKYO--(BUSINESS WIRE)--#IVD--H.U. Group Holdings Inc. and its wholly-owned subsidiary Fujirebio today announced the availability of the Lumipulse G pTau 217 CSF assay ...

News-Gazette Radio airs from 4-5 p.m. Monday through Thursday on WDWS 1400-AM and streams on news-gazette.com. After a years-long campaign to ban carbon sequestration near the Mahomet Aquifer resulted ...

1 Department of Intensive Care Unit, Affiliated Jinhua Hospital, Zhejiang University School of Medicine, Jinhua, China 2 Department of Hepatobiliary and Pancreatic Surgery, Affiliated Jinhua Hospital, ...

A CAT score improvement greater than the MCID was achieved by 81.0% of study participants with COPD using BDP/FF/G inhaled triple therapy for 6 months. A triple inhalation therapy administered via dry ...

A historical perspective on traditional factor replacement therapies, tracing their development, successes, and ongoing limitations such as short half-life, infusion requirements, and inhibitor ...

This video showcases the BMW G82 M4 Performance Build, featuring Mosselman upgraded turbos, a CSF high-performance inlet system, and a 1000 hp dyno session. The project focuses on extracting maximum ...

A study published in the Journal of Cannabis Research examined the effect of granulocyte colony-stimulating factor (G-CSF) on brain recovery following traumatic brain injury (TBI). The findings showed ...

The Supreme Court’s decision in a case challenging Colorado’s ban on conversion therapy for minors would have implications for many states with similar laws. By Amy Harmon It was in 2012, three years ...